NextPlat (NXPL) Current Assets (2010 - 2026)
NextPlat's (NXPL) quarterly Current Assets came in at $25.1 million in Q2 2026, down 6.36% year-over-year from $26.9 million in Q2 2025, and up 8.13% quarter-over-quarter from $23.3 million in Q1 2026.
Analysis
NextPlat (NXPL) Current Assets (2010 - 2026) Analysis & Trends
NextPlat (NXPL) has reported Current Assets for 15 consecutive years, with $25.1 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Current Assets fell 6.36% year-over-year to $25.1 million in Q2 2026; TTM through Jun 2026 was $25.1 million, a 6.36% decrease from a year earlier, with the FY2025 full-year figure at $24.2 million, down 24.7% from the prior year.
- Current Assets was $25.1 million for Q2 2026 at NextPlat, up from $23.3 million in the prior quarter.
- Over five years, Current Assets peaked at $45.3 million in Q1 2024 and troughed at $14.8 million in Q3 2022.
- A 5-year average of $29.3 million and a median of $25.7 million in 2025 frame the typical range for Current Assets.
- Across the five-year window, Current Assets surged 1471.02% in 2022 and plunged 36.12% in 2025, its largest moves.
- Over 5 years, Current Assets stood at $21.2 million in 2022, then surged by 106.0% to $43.6 million in 2023, then decreased by 26.49% to $32.1 million in 2024, then dropped by 24.7% to $24.2 million in 2025, then grew by 4.1% to $25.1 million in 2026.
- The last three Current Assets figures came in at $25.1 million (Q2 2026), $23.3 million (Q1 2026), and $24.2 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | 13.76 Bn |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | 10.06 Bn |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | 3.16 Bn |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | 1.95 Bn |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | 6.52 Bn |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | 825.43 Mn |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | 544.97 Mn |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | 630.95 Mn |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | 72.50 Mn |
| 10 | NextPlat | 24.77 Mn | 12.93 Mn | 4.69 Mn | 25.15 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 25.15 Mn |
| Mar 31, 2026 | 23.26 Mn |
| Dec 31, 2025 | 24.16 Mn |
| Sep 30, 2025 | 26.21 Mn |
| Jun 30, 2025 | 26.86 Mn |
| Mar 31, 2025 | 30.48 Mn |
| Dec 31, 2024 | 32.08 Mn |
| Sep 30, 2024 | 35.79 Mn |
| Jun 30, 2024 | 42.04 Mn |
| Mar 31, 2024 | 45.34 Mn |
| Dec 31, 2023 | 43.64 Mn |
| Sep 30, 2023 | 43.74 Mn |
| Jun 30, 2023 | 24.22 Mn |
| Mar 31, 2023 | 20.43 Mn |
| Dec 31, 2022 | 21.18 Mn |
| Sep 30, 2022 | 14.84 Mn |
| Jun 30, 2022 | 22.83 Mn |
| Mar 31, 2022 | 24.48 Mn |
| Dec 31, 2021 | 19.37 Mn |
| Sep 30, 2021 | 19.01 Mn |